Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from HeraMED Ltd. ( (AU:HMD) ) is now available.
HeraMED Ltd. has reported a change in the shareholding of director Sharon Richardson, who increased her direct holding in the company through participation in a recent capital placement. Her fully paid ordinary shareholding rose from 2,200,003 to 3,637,503 shares, while her existing 2,000,000 unlisted options, exercisable at $0.03 and expiring in February 2029, remain unchanged.
The additional 1,437,500 shares were acquired for $57,500 via a placement previously approved by shareholders at an extraordinary general meeting on 26 March 2026. The transaction did not occur during a closed period, indicating standard governance procedures and signaling ongoing insider support for the company’s equity raising efforts.
The most recent analyst rating on (AU:HMD) stock is a Hold with a A$0.05 price target. To see the full list of analyst forecasts on HeraMED Ltd. stock, see the AU:HMD Stock Forecast page.
More about HeraMED Ltd.
HeraMED Ltd. is a listed company, but the provided document offers no details on its industry, products, services, or target markets. The filing focuses solely on a change in director shareholdings, without operational or strategic context about the business itself.
YTD Price Performance: 27.78%
Average Trading Volume: 897,527
Technical Sentiment Signal: Buy
Current Market Cap: A$53.13M
For detailed information about HMD stock, go to TipRanks’ Stock Analysis page.